Andrea Pirzkall's most recent trade in Replimune Group Inc was a trade of 30,750 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on April 1, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Replimune Group Inc | Andrea Pirzkall | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 30,750 | 30,750 | - | - | Employee Stock Option (right to buy) | |
Replimune Group Inc | Andrea Pirzkall | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 20,500 | 21,500 (0%) | 0% | 0 | Common Stock | |
Replimune Group Inc | Andrea Pirzkall | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2020 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) |